Search results
Was COVID vaccine recalled over health danger fears? What we know
Newsweek· 6 days agoPharmaceutical company AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine just...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 57 minutes agoAfter hitting a two-year high in February, biotech stocks sloughed off in April but have started to...
Jacob Rees-Mogg claims UK government 'downplayed' risks of AstraZeneca COVID vaccine
Yahoo News UK· 5 days agoIn the first year, vaccinations were estimated to have prevented 19.8 million COVID-19 deaths...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 1 day agoIf approved, Moderna plans to launch the vaccine this fall for people age 60 and older. This puts it...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
What's Going With Moderna Stock On Friday? - Moderna (NASDAQ:MRNA)
Benzinga· 5 days agoThe Food and Drug Administration (FDA) notified Moderna Inc MRNA on Friday that its review of a new vaccine has been delayed. The agency, citing administrative constraints ...
Healthcare Giants Pfizer, AstraZeneca, Sanofi Inject Over $2B To Boost France's Healthcare Sector -...
Benzinga· 2 days agoPfizer and AstraZeneca invest over $1 billion in France's healthcare sector, bolstering R&D...
There might be stockpiles, but making an effective bird flu vaccine won’t be quick or easy
The Telegraph via Yahoo News· 1 day agoHealth officials have been steadfast in their assurances. The risk of H5N1 bird flu jumping into...
Pfizer whistleblower shares chilling video: ‘Tired of feeling like I have no hope…but I am NOT...
BizPac Review· 6 days agoA woman has come forward claiming to be a Pfizer whistleblower with a helluva story to tell about the pharmaceutical giant. In addition, she’s published an ominous video declaring ...
AstraZeneca pulls its COVID-19 vaccine from European market after history of stumbles
Fortune· 6 days agoAstraZeneca’s COVID-19 vaccine was first given the nod by the EMA in January 2021. Within weeks, however, concerns grew about the vaccine’s safety, when ...